Millennium Group Management LLC insider trades: Sensei Biotherapeutics (SNSE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Millennium Group Management LLC reports to the SEC
and 2 more companies
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | SNSE | ↓ Sell | 17,076 | $31.51 | $538K | Indirect | May 15, 2026 (38d) |
| Apr 7, 2026 | SNSE | ↑ Buy | 4,215 | $33.54 | $141K | Indirect | May 15, 2026 (38d) |
| Apr 1, 2026 | SNSE | ↑ Buy | 12,180 | $31.37 | $382K | Indirect | May 15, 2026 (44d) |
| Apr 1, 2026 | SNSE | ↓ Sell | 2,741 | $28.07 | $77K | Indirect | May 15, 2026 (44d) |
| Mar 30, 2026 | SNSE | ↑ Buy | 30,585 | $26.75 | $818K | Indirect | May 15, 2026 (46d) |
| Mar 30, 2026 | SNSE | ↓ Sell | 3,250 | $27.50 | $89K | Indirect | May 15, 2026 (46d) |
| Dec 17, 2021 | DSAC | ↓ Sell | 300,000 | $9.87 | $3.0M | Indirect | Dec 21, 2021 (4d) |
| Nov 12, 2021 | DSAC | ↑ Buy | 85,454 | $9.92 | $847K | Indirect | Dec 21, 2021 (39d) |
| Jun 3, 2020 | MFAC | ↓ Sell | 210,000 | $10.45 | $2.2M | Direct | Jun 4, 2020 (1d) |
| Jan 9, 2014 | LBMH | ↓ Sell | 279,123 | $4.67 | $1.3M | Direct | Jan 10, 2014 (1d) |
| Dec 24, 2013 | LBMH | ↓ Sell | 100,000 | $4.36 | $436K | Direct | Dec 24, 2013 (0d) |
| Nov 29, 2013 | LBMH | ↓ Sell | 75,000 | $3.65 | $274K | Direct | Dec 3, 2013 (4d) |
| Nov 25, 2013 | LBMH | ↓ Sell | 180,000 | $3.20 | $576K | Direct | Nov 26, 2013 (1d) |
| Oct 14, 2013 | LBMH | ↓ Sell | 240,000 | $2.20 | $528K | Direct | Oct 16, 2013 (2d) |
| Sep 17, 2013 | LBMH | ↓ Sell | 215,000 | $2.25 | $484K | Direct | Sep 19, 2013 (2d) |
| Jul 15, 2013 | LBMH | ↓ Sell | 300,000 | $1.83 | $549K | Direct | Jul 17, 2013 (2d) |
| May 25, 2010 | LBMH | ↓ Sell | 200 | $1.57 | $315 | Direct | May 28, 2010 (3d) |
| Dec 15, 2008 | STTA | ↑ Buy | 70,000 | $7.22 | $506K | Direct | Dec 24, 2008 (9d) |
| Nov 3, 2008 | GSL | ↓ Sell | 68,700 | $3.00 | $206K | Direct | Feb 17, 2009 (106d) |
| Oct 30, 2008 | GSL | ↓ Sell | 118,166 | $3.09 | $366K | Direct | Oct 31, 2008 (1d) |
| Oct 24, 2008 | GSL | ↑ Buy | 10 | $3.58 | $36 | Direct | Feb 17, 2009 (116d) |
| Oct 23, 2008 | GSL | ↓ Sell | 17,784 | $4.00 | $71K | Direct | Oct 24, 2008 (1d) |
| Oct 14, 2008 | GSL | ↓ Sell | 99,900 | $4.11 | $410K | Direct | Oct 16, 2008 (2d) |
| Oct 13, 2008 | GSL | ↓ Sell | 39,836 | $3.87 | $154K | Direct | Oct 14, 2008 (1d) |
| Oct 8, 2008 | GSL | ↓ Sell | 44,000 | $3.81 | $168K | Direct | Oct 10, 2008 (2d) |
| Oct 6, 2008 | GSL | ↓ Sell | 20,300 | $5.00 | $102K | Direct | Oct 8, 2008 (2d) |
| Oct 2, 2008 | GSL | ↓ Sell | 4,156 | $6.15 | $26K | Direct | Oct 6, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SNSE insiders
Open-market trades in the last 12 months
About Millennium Group Management LLC's insider trades
Millennium Group Management LLC is a 10% owner of Sensei Biotherapeutics (SNSE). Since Oct 2, 2008, it has reported 6 open-market purchases worth $2.7M and 21 sales worth $11.5M on SEC Form 4. In the last 12 months: 3 buys ($1.3M) and 3 sales ($704K).
Its filings also include other transactions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNSE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.